FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	1
2024	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FAEGRE DRINKER BIDDLE & REATH LLP	—	13

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	12
SENATE	12
Defense, Dept of (DOD)	6
Food & Drug Administration (FDA)	6
Health & Human Services, Dept of (HHS)	6
Natl Institutes of Health (NIH)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	13

FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS — Lobbying Disclosure | Poliscope